Shares slumped as the latest in a wave of analyst downgrades hit Public Service Enterprise Group, raising a pointed question: is the market pricing out one of America's biggest nuclear-powered utilities just weeks before its earnings report?
A $10 Target Cut Signals More Than Routine Caution. BTIG lowered its price target on PSEG to $84 from $94 , a roughly 11% haircut, citing election-related uncertainty and rising interest rates as headwinds for the entire utility sector. The cut wasn't isolated. JPMorgan trimmed its target to $77 from $81 , and Truist lowered its target to $78 from $84 while maintaining a Hold rating . When BTIG first initiated coverage, the firm set a Buy rating and a $98 price target — meaning the new $84 figure represents a 14% reduction from its original conviction call. For shareholders, the pattern is clear: Wall Street's confidence ceiling is dropping fast.
The Stock Is Flirting With Its 52-Week Low. At $67.63, PEG is now just 2.2% above its 52-week low of $66.15 . Year-to-date, the stock has declined roughly 8–12% , badly lagging the broader market. Yet the average analyst price target remains around $83, implying about 23% upside — a gap wide enough to signal the market either doubts analyst models or sees risks they haven't priced in. Earnings are due November 2 , making the next two weeks a critical test.
Data Center Power Demand Is the Bull Case — But It's Still Mostly Promises. PSEG owns roughly 3,800 MW of nuclear capacity and saw its large-load pipeline surge 47% in one quarter to 9.4 GW, driven primarily by data center requests . Management has cautioned that only 10–20% of those requests will likely come online . The company is planning a 200 MW uprate at its Salem nuclear plant during 2027–2029 and reaffirmed $21–24 billion in capital spending through 2029 . That spending underpins 2026 EPS guidance of $4.28–$4.40, representing about 7% growth . But until hyperscaler contracts are signed, the data center narrative adds hope, not cash flow.
Insider Selling Doesn't Inspire Confidence. On October 1, CEO Ralph LaRossa sold 2,083 shares at prices near $67–$68, totaling roughly $140,570 . Insiders have sold $2.9 million in shares over the past 12 months with no buying activity . Small transactions don't signal panic, but a zero-buy record undercuts any claim that management sees a bargain at these prices.